{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Antiviral phytochemicals", "Molecular dynamics (MD) simulation", "S-Protein blocker", "SARS-CoV-2 novel coronavirus"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33647752", "DateCompleted": {"Year": "2021", "Month": "06", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "21"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "02", "Day": "22"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jmgm.2021.107874", "S1093-3263(21)00043-7"], "Journal": {"ISSN": "1873-4243", "JournalIssue": {"Volume": "105", "PubDate": {"Year": "2021", "Month": "Jun"}}, "Title": "Journal of molecular graphics & modelling", "ISOAbbreviation": "J Mol Graph Model"}, "ArticleTitle": "Pinpointing the potential hits for hindering interaction of SARS-CoV-2 S-protein with ACE2 from the pool of antiviral phytochemicals utilizing molecular docking and molecular dynamics (MD) simulations.", "Pagination": {"StartPage": "107874", "MedlinePgn": "107874"}, "Abstract": {"AbstractText": ["SARS-CoV-2, the viral particle, is responsible for triggering the 2019 Coronavirus disease outbreak (COVID-19). To tackle this situation, a number of strategies are being devised to either create an antidote, a vaccine, or agents capable of preventing its infection. To enable research on these strategies, numerous target proteins are identified where Spike (S) protein is presumed to be of immense potential. S-protein interacts with human angiotensin-converting-enzyme-2 (ACE2) for cell entry. The key region of S-protein that interacts with ACE2 is a portion of it designated as a receptor-binding domain (RBD), following whereby the viral membrane fuses with the alveolar membrane to enter the human cell. The proposition is to recognize molecules from the bundle of phytochemicals of medicinal plants known to possess antiviral potentials as a lead that could interact and mask RBD, rendering them unavailable to form ACE2 interactions. Such a molecule is called the 'S-protein blocker'. A total of 110 phytochemicals from Withania somnifera, Asparagus racemosus, Zinziber officinalis, Allium sativum, Curcuma longa and Adhatoda vasica were used in the study, of which Racemoside A, Ashwagandhanolide, Withanoside VI, Withanoside IV and Racemoside C were identified as top five hits using molecular docking. Further, essential Pharmacophore features and their ADMET profiles of these compounds were studied following to which the best three hits were analyzed for their interaction with RBD using Molecular Dynamics (MD) simulation. Binding free energy calculations were performed using MM/GBSA, proving these phytochemicals can serve as S-protein blocker."], "CopyrightInformation": "Copyright \u00a9 2021 Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany, Bioinformatics, and Climate Change Impacts Management, School of Sciences, Gujarat University, Ahmedabad, 380009, India."}], "LastName": "Patel", "ForeName": "Chirag N", "Initials": "CN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology & Biotechnology, School of Sciences, Gujarat University, Ahmedabad, 380009, Gujarat, India."}], "LastName": "Goswami", "ForeName": "Dweipayan", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany, Bioinformatics, and Climate Change Impacts Management, School of Sciences, Gujarat University, Ahmedabad, 380009, India."}], "LastName": "Jaiswal", "ForeName": "Dharmesh G", "Initials": "DG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Zoology, School of Sciences, Gujarat University, Ahmedabad, 380009, India."}], "LastName": "Parmar", "ForeName": "Robin M", "Initials": "RM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany, Bioinformatics, and Climate Change Impacts Management, School of Sciences, Gujarat University, Ahmedabad, 380009, India."}], "LastName": "Solanki", "ForeName": "Hitesh A", "Initials": "HA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany, Bioinformatics, and Climate Change Impacts Management, School of Sciences, Gujarat University, Ahmedabad, 380009, India. Electronic address: hapandya@gujaratuniversity.ac.in."}], "LastName": "Pandya", "ForeName": "Himanshu A", "Initials": "HA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Mol Graph Model", "NlmUniqueID": "9716237", "ISSNLinking": "1093-3263"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Spike Glycoprotein, Coronavirus"}, {"RegistryNumber": "0", "NameOfSubstance": "spike protein, SARS-CoV-2"}, {"RegistryNumber": "EC 3.4.15.1", "NameOfSubstance": "Peptidyl-Dipeptidase A"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "Angiotensin-Converting Enzyme 2"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Angiotensin-Converting Enzyme 2"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Peptidyl-Dipeptidase A"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Phytochemicals"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Spike Glycoprotein, Coronavirus"}], "CoiStatement": "Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Schwartz D.A., Graham A.L. Potential maternal and infant outcomes from coronavirus 2019-NCOV (SARS-CoV-2) infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses. 2020;12 doi: 10.3390/v12020194.", "ArticleIdList": ["10.3390/v12020194", "PMC7077337", "32050635"]}, {"Citation": "Joshi R.S., Jagdale S.S., Bansode S.B., Shiva Shankar S., Tellis M.B., Pandya K., Chugh A., Giri A.P., Kulkarni M.J., Joshi S. Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease. J.\u00a0Biomol. Struct. Dyn. 2020:1\u201316. doi: 10.1080/07391102.2020.1760137. Taylor Fr.", "ArticleIdList": ["10.1080/07391102.2020.1760137", "PMC7212545", "32329408"]}, {"Citation": "Chen Y., Guo Y., Pan Y., Zhao Z.J. Structure analysis of the receptor binding of 2019-nCoV. Biochem. Biophys. Res. Commun. 2020 doi: 10.1016/j.bbrc.2020.02.071.", "ArticleIdList": ["10.1016/j.bbrc.2020.02.071", "PMC7092824", "32081428"]}, {"Citation": "Song Z., Xu Y., Bao L., Zhang L., Yu P., Qu Y., Zhu H., Zhao W., Han Y., Qin C. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019;11 doi: 10.3390/v11010059.", "ArticleIdList": ["10.3390/v11010059", "PMC6357155", "30646565"]}, {"Citation": "Wu F., Zhao S., Yu B., Chen Y.M., Wang W., Song Z.G., Hu Y., Tao Z.W., Tian J.H., Pei Y.Y., Yuan M.L., Zhang Y.Z.Y.Z.L., Dai F.H., Liu Y., Wang Q.M., Zheng J.J., Xu L., Holmes E.C., Zhang Y.Z.Y.Z.L. A\u00a0new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265\u2013269. doi: 10.1038/s41586-020-2008-3.", "ArticleIdList": ["10.1038/s41586-020-2008-3", "PMC7094943", "32015508"]}, {"Citation": "Rao P., Shukla A., Parmar P., Rawal R.M., Patel B., Saraf M., Goswami D. Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (Mpro) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation. Biophys. Chem. 2020 doi: 10.1016/j.bpc.2020.106425.", "ArticleIdList": ["10.1016/j.bpc.2020.106425", "PMC7836334", "32663708"]}, {"Citation": "Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506. doi: 10.1016/S0140-6736(20)30183-5.", "ArticleIdList": ["10.1016/S0140-6736(20)30183-5", "PMC7159299", "31986264"]}, {"Citation": "Kong R., Yang G., Xue R., Liu M., Wang F., Hu J., Guo X., Chang S.  J ArXiv Prepr.; 2020. COVID-19 Docking Server: an Interactive Server for Docking Small Molecules, Peptides and Antibodies against Potential Targets of COVID-19.https://arxiv.org/abs/2003.00163", "ArticleIdList": ["PMC7558834", "32692801"]}, {"Citation": "Rao P., Shukla A., Parmar P., Rawal R., Patel B., Saraf M., Goswami D. Proposing a fungal metabolite-Flaviolin as a potential inhibitor of 3CLpro of novel coronavirus SARS-CoV-2 identified using Docking and Molecular Dynamics. J.\u00a0Biomol. Struct. Dyn. 2020 doi: 10.1080/07391102.2020.1813202.", "ArticleIdList": ["10.1080/07391102.2020.1813202", "32875950"]}, {"Citation": "Chen X., Li R., Pan Z., Qian C., Yang Y., You R., Zhao J., Liu P., Gao L., Li Z., Huang Q., Xu L., Tang J., Tian Q., Yao W., Hu L., Yan X., Zhou X., Wu Y., Deng K., Zhang Z., Qian Z., Chen Y., Ye L. Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor. Cell. Mol. Immunol. 2020;17:647\u2013649. doi: 10.1038/s41423-020-0426-7.", "ArticleIdList": ["10.1038/s41423-020-0426-7", "PMC7167496", "32313207"]}, {"Citation": "Shang J., Wan Y., Luo C., Ye G., Geng Q., Auerbach A., Li F. Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. U. S. A. 2020;117 doi: 10.1073/pnas.2003138117.", "ArticleIdList": ["10.1073/pnas.2003138117", "PMC7260975", "32376634"]}, {"Citation": "Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., Guo L., Guo R., Chen T., Hu J., Xiang Z., Mu Z., Chen X., Chen J., Hu K., Jin Q., Wang J., Qian Z. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat. Commun. 2020;11 doi: 10.1038/s41467-020-15562-9.", "ArticleIdList": ["10.1038/s41467-020-15562-9", "PMC7100515", "32221306"]}, {"Citation": "Shang J., Ye G., Shi K., Wan Y., Luo C., Aihara H., Geng Q., Auerbach A., Li F. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581:221\u2013224. doi: 10.1038/s41586-020-2179-y.", "ArticleIdList": ["10.1038/s41586-020-2179-y", "PMC7328981", "32225175"]}, {"Citation": "Trezza A., Iovinelli D., Santucci A., Prischi F., Spiga O. An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors. Sci. Rep. 2020;10:1\u20138. doi: 10.1038/s41598-020-70863-9.", "ArticleIdList": ["10.1038/s41598-020-70863-9", "PMC7431416", "32807895"]}, {"Citation": "Xia S., Yan L., Xu W., Agrawal A.S., Algaissi A., Tseng C.T.K., Wang Q., Du L., Tan W., Wilson I.A., Jiang S., Yang B., Lu L. A\u00a0pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Sci. Adv. 2019;5:eaav4580. doi: 10.1126/sciadv.aav4580.", "ArticleIdList": ["10.1126/sciadv.aav4580", "PMC6457931", "30989115"]}, {"Citation": "Xia S., Zhu Y., Liu M., Lan Q., Xu W., Wu Y., Ying T., Liu S., Shi Z., Jiang S., Lu L. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein, Cell. Mol. Immunol. 2020;17:765\u2013767. doi: 10.1038/s41423-020-0374-2.", "ArticleIdList": ["10.1038/s41423-020-0374-2", "PMC7075278", "32047258"]}, {"Citation": "Sinha S.K., Prasad S.K., Islam M.A., Gurav S.S., Patil R.B., AlFaris N.A., Aldayel T.S., AlKehayez N.M., Wabaidur S.M., Shakya A. Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study. J.\u00a0Biomol. Struct. Dyn. 2020:1\u201315. doi: 10.1080/07391102.2020.1779132.", "ArticleIdList": ["10.1080/07391102.2020.1779132", "PMC7309308", "32552462"]}, {"Citation": "Huang Y., Yang C., feng Xu X., Xu W., wen Liu S. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol. Sin. 2020:1\u20139. doi: 10.1038/s41401-020-0485-4.", "ArticleIdList": ["10.1038/s41401-020-0485-4", "PMC7396720", "32747721"]}, {"Citation": "Mwitari P.G., Ayeka P.A., Ondicho J., Matu E.N., Bii C.C. Antimicrobial activity and probable mechanisms of action of medicinal plants of Kenya: Withania somnifera, Warbugia ugandensis, Prunus africana and Plectrunthus barbatus. PloS One. 2013;8 doi: 10.1371/journal.pone.0065619.", "ArticleIdList": ["10.1371/journal.pone.0065619", "PMC3681961", "23785437"]}, {"Citation": "Sabde S., Bodiwala H.S., Karmase A., Deshpande P.J., Kaur A., Ahmed N., Chauthe S.K., Brahmbhatt K.G., Phadke R.U., Mitra D., Bhutani K.K., Singh I.P. Anti-HIV activity of Indian medicinal plants. J.\u00a0Nat. Med. 2011;65:662\u2013669. doi: 10.1007/s11418-011-0513-2.", "ArticleIdList": ["10.1007/s11418-011-0513-2", "21365365"]}, {"Citation": "Lamari Z., Larbi R., Negache H. Trace element content of Zingiber officinalis and Salvia officinalis medicinal plants from Algeria. J.\u00a0Radioanal. Nucl. Chem. 2016;309:17\u201322. doi: 10.1007/s10967-016-4858-6.", "ArticleIdList": ["10.1007/s10967-016-4858-6"]}, {"Citation": "Balasubramanian G., Sarathi M., Kumar S.R., Hameed A.S.S. Screening the antiviral activity of Indian medicinal plants against white spot syndrome virus in shrimp. Aquaculture. 2007;263:15\u201319. doi: 10.1016/j.aquaculture.2006.09.037.", "ArticleIdList": ["10.1016/j.aquaculture.2006.09.037"]}, {"Citation": "Dao T.T., Nguyen P.H., Won H.K., Kim E.H., Park J., Won B.Y., Oh W.K. Curcuminoids from Curcuma longa and their inhibitory activities on influenza A neuraminidases. Food Chem. 2012;134:21\u201328. doi: 10.1016/j.foodchem.2012.02.015.", "ArticleIdList": ["10.1016/j.foodchem.2012.02.015"]}, {"Citation": "Krieger E., Darden T., Nabuurs S.B., Finkelstein A., Vriend G. vol. 57. Wiley Online Libr; 2004. pp. 678\u2013683. (Making Optimal Use of Empirical Energy Functions: Force-Field Parameterization in Crystal Space).", "ArticleIdList": ["10.1002/prot.20251", "15390263"]}, {"Citation": "Krieger E., Vriend G. New ways to boost molecular dynamics simulations. J.\u00a0Comput. Chem. 2015;36:996\u20131007. doi: 10.1002/jcc.23899.", "ArticleIdList": ["10.1002/jcc.23899", "PMC6680170", "25824339"]}, {"Citation": "Trott O., Olson A.J., Vina AutoDock. Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J.\u00a0Comput. Chem. 2010;31:455\u2013461. doi: 10.1002/jcc.21334.", "ArticleIdList": ["10.1002/jcc.21334", "PMC3041641", "19499576"]}, {"Citation": "Pires D.E.V., Blundell T.L., Ascher D.B. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J.\u00a0Med. Chem. 2015;58:4066\u20134072. doi: 10.1021/acs.jmedchem.5b00104.", "ArticleIdList": ["10.1021/acs.jmedchem.5b00104", "PMC4434528", "25860834"]}, {"Citation": "Patel C.N., Kumar S.P., Modi K.M., Soni M.N., Modi N.R., Pandya H.A. Cardiotonic steroids as potential Na+/K+-ATPase inhibitors\u2013a computational study. J.\u00a0Recept. Signal Transduct. 2019;39:226\u2013234. doi: 10.1080/10799893.2019.1660893.", "ArticleIdList": ["10.1080/10799893.2019.1660893", "31509043"]}, {"Citation": "Wang W., Donini O., Reyes C.M., Kollman P.A. Biomolecular simulations: recent developments in force fields, simulations of enzyme catalysis, protein-ligand, protein-protein, and protein-nucleic acid noncovalent interactions. Annu. Rev. Biophys. Biomol. Struct. 2001;30:211\u2013243. doi: 10.1146/annurev.biophys.30.1.211.", "ArticleIdList": ["10.1146/annurev.biophys.30.1.211", "11340059"]}, {"Citation": "Wang J., Hou T., Xu X. Recent advances in free energy calculations with a combination of molecular mechanics and continuum models. Curr. Comput. Aided Drug Des. 2006;2:287\u2013306. doi: 10.2174/157340906778226454.", "ArticleIdList": ["10.2174/157340906778226454"]}, {"Citation": "Kollman P.A., Massova I., Reyes C., Kuhn B., Huo S., Chong L., Lee M., Lee T., Duan Y., Wang W., Donini O., Cieplak P., Srinivasan J., Case D.A., Cheatham T.E. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc. Chem. Res. 2000;33:889\u2013897. doi: 10.1021/ar000033j.", "ArticleIdList": ["10.1021/ar000033j", "11123888"]}, {"Citation": "Massova I., Kollman P.A. Combined molecular mechanical and continuum solvent approach (MM- PBSA/GBSA) to predict ligand binding. Perspect. Drug Discov. Des. 2000;18:113\u2013135. doi: 10.1023/A:1008763014207.", "ArticleIdList": ["10.1023/A:1008763014207"]}, {"Citation": "Xia S., Liu M., Wang C., Xu W., Lan Q., Feng S., Qi F., Bao L., Du L., Liu S., Qin C., Sun F., Shi Z., Zhu Y., Jiang S., Lu L. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 2020;30:343\u2013355. doi: 10.1038/s41422-020-0305-x.", "ArticleIdList": ["10.1038/s41422-020-0305-x", "PMC7104723", "32231345"]}, {"Citation": "Yu R., Chen L., Lan R., Shen R., Li P. Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking. Int. J. Antimicrob. Agents. 2020;56 doi: 10.1016/j.ijantimicag.2020.106012.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.106012", "PMC7205718", "32389723"]}, {"Citation": "Yang J., Petitjean S., Derclaye S., Koehler M., Zhang Q., Dumitru A., Soumillion P., Alsteens D. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Res. Sq. 2020 doi: 10.21203/rs.3.rs-30468/v1.", "ArticleIdList": ["10.21203/rs.3.rs-30468/v1", "PMC7486399", "32917884"]}, {"Citation": "Baig M.S., Alagumuthu M., Rajpoot S., Saqib U. Identification of a potential peptide inhibitor of SARS-CoV-2 targeting its entry into the host cells. Drugs R. 2020;20:161\u2013169. doi: 10.1007/s40268-020-00312-5.", "ArticleIdList": ["10.1007/s40268-020-00312-5", "PMC7319219", "32592145"]}, {"Citation": "Wong F.-C., Ong J.-H., Chai T.-T. EFood; 2020. Identification of Putative Cell-Entry-Inhibitory Peptides against SARS-CoV-2 from Edible Insects: an in Silico Study.", "ArticleIdList": ["10.2991/efood.k.200918.002"]}, {"Citation": "Alagumuthu M., Rajpoot S., Baig M.S. Structure-based design of novel peptidomimetics targeting the SARS-CoV-2 spike protein. Cell. Mol. Bioeng. 2020 doi: 10.1007/s12195-020-00658-5.", "ArticleIdList": ["10.1007/s12195-020-00658-5", "PMC7553367", "33072222"]}, {"Citation": "Sch\u00fctz D., Ruiz-Blanco Y.B., M\u00fcnch J., Kirchhoff F., Sanchez-Garcia E., M\u00fcller J.A. Peptide and peptide-based inhibitors of SARS-CoV-2 entry. Adv. Drug Deliv. Rev. 2020;167:47\u201365. doi: 10.1016/j.addr.2020.11.007.", "ArticleIdList": ["10.1016/j.addr.2020.11.007", "PMC7665879", "33189768"]}, {"Citation": "Rathod S.B., Prajapati P.B., Punjabi L.B., Prajapati K.N., Chauhan N., Mansuri M.F. Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2. Silico Pharmacol. 2020;8 doi: 10.1007/s40203-020-00055-w.", "ArticleIdList": ["10.1007/s40203-020-00055-w", "PMC7649901", "33184600"]}, {"Citation": "Bhattacharya R., Gupta A.M., Mitra S., Mandal S., Biswas S.R. A\u00a0natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2. Virology. 2021;552:107\u2013111. doi: 10.1016/j.virol.2020.10.002.", "ArticleIdList": ["10.1016/j.virol.2020.10.002", "PMC7598437", "33130382"]}, {"Citation": "de Oliveira O.V., Rocha G.B., Paluch A.S., Costa L.T. Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening. J.\u00a0Biomol. Struct. Dyn. 2020:1\u201310. doi: 10.1080/07391102.2020.1772885.", "ArticleIdList": ["10.1080/07391102.2020.1772885", "PMC7284156", "32448085"]}, {"Citation": "Kalhor H., Sadeghi S., Abolhasani H., Kalhor R., Rahimi H. Repurposing of the approved small molecule drugs in order to inhibit SARS-CoV-2 S protein and human ACE2 interaction through virtual screening approaches. J.\u00a0Biomol. Struct. Dyn. 2020 doi: 10.1080/07391102.2020.1824816.", "ArticleIdList": ["10.1080/07391102.2020.1824816", "PMC7576931", "32969333"]}, {"Citation": "Unni S., Aouti S., Thiyagarajan S., Padmanabhan B. Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods. J.\u00a0Biosci. 2020;45 doi: 10.1007/s12038-020-00102-w.", "ArticleIdList": ["10.1007/s12038-020-00102-w", "PMC7561504", "33184246"]}, {"Citation": "Pandey P., Rane J.S., Chatterjee A., Kumar A., Khan R., Prakash A., Ray S. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development. J.\u00a0Biomol. Struct. Dyn. 2020:1\u201311. doi: 10.1080/07391102.2020.1796811.", "ArticleIdList": ["10.1080/07391102.2020.1796811", "PMC7441770", "32698689"]}, {"Citation": "Muhseen Z.T., Hameed A.R., Al-Hasani H.M.H., Tahir ul Qamar M., Li G. Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: integrated computational approach. J.\u00a0Mol. Liq. 2020;320 doi: 10.1016/j.molliq.2020.114493.", "ArticleIdList": ["10.1016/j.molliq.2020.114493", "PMC7538380", "33041407"]}, {"Citation": "Ravichandran K., Sankar M. In silico molecular docking analysis of targeting SARS-CoV-2 spike protein and selected herbal constituents. Artic. J. Pure Appl. Microbiol. 2020 doi: 10.22207/JPAM.14.SPL1.37.", "ArticleIdList": ["10.22207/JPAM.14.SPL1.37"]}, {"Citation": "Bhardwaj V.K., Singh R., Sharma J., Rajendran V., Purohit R., Kumar S. Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors. J.\u00a0Biomol. Struct. Dyn. 2020:1\u201310. doi: 10.1080/07391102.2020.1766572.", "ArticleIdList": ["10.1080/07391102.2020.1766572", "PMC7256349", "32397940"]}, {"Citation": "Bhardwaj V.K., Purohit R. Targeting the protein-protein interface pocket of Aurora-A-TPX2 complex: rational drug design and validation. J.\u00a0Biomol. Struct. Dyn. 2020 doi: 10.1080/07391102.2020.1772109.", "ArticleIdList": ["10.1080/07391102.2020.1772109", "32448055"]}, {"Citation": "Arya R., Das A., Prashar V., Kumar M. 2020. Potential Inhibitors against Papain-like Protease of Novel Coronavirus (SARS-CoV-2) from FDA Approved Drugs."}, {"Citation": "Parmar P., Shukla A., Rao P., Saraf M., Patel B., Goswami D.%J.B.C. 2020. The Rise of Gingerol as Anti-QS Molecule: Darkest Episode in the LuxR-Mediated Bioluminescence Saga.", "ArticleIdList": ["32283347"]}, {"Citation": "Shukla A., Parmar P., Rao P., Goswami D., Saraf M. Twin peaks: presenting the antagonistic molecular interplay of Curcumin with LasR and LuxR quorum sensing pathways. Curr. Microbiol. 2020 doi: 10.1007/s00284-020-01997-2.", "ArticleIdList": ["10.1007/s00284-020-01997-2", "32333184"]}, {"Citation": "Kumar S.P., Patel C.N., Rawal R.M., Pandya H.A. Energetic contributions of amino acid residues and its cross-talk to delineate ligand-binding mechanism. Proteins Struct. Funct. Bioinf. 2020;88:1207\u20131225. doi: 10.1002/prot.25894.", "ArticleIdList": ["10.1002/prot.25894", "32323374"]}, {"Citation": "Mukherjee S., Dasgupta S., Adhikary T., Adhikari U., Panja S.S. Structural insight to hydroxychloroquine-3C-like proteinase complexation from SARS-CoV-2: inhibitor modelling study through molecular docking and MD-simulation study. J.\u00a0Biomol. Struct. Dyn. 2020:1\u201313. doi: 10.1080/07391102.2020.1804458.", "ArticleIdList": ["10.1080/07391102.2020.1804458", "PMC7484585", "32772895"]}, {"Citation": "Bomzan D.P., Shilpashree H.B., Anjali P., Kumar S.R., Nagegowda D.A. Methods Mol. Biol. Humana Press Inc.; 2020. Virus-induced gene silencing for functional genomics in withania somnifera, an important indian medicinal plant; pp. 139\u2013154.", "ArticleIdList": ["10.1007/978-1-0716-0751-0_11", "32557367"]}, {"Citation": "Subbaraju G.V., Vanisree M., Rao C.V., Sivaramakrishna C., Sridhar P., Jayaprakasam B., Nair M.G. Ashwagandhanolide, a bioactive dimeric thiowithanolide isolated from the roots of Withania somnifera. J.\u00a0Nat. Prod. 2006;69:1790\u20131792. doi: 10.1021/np060147p.", "ArticleIdList": ["10.1021/np060147p", "17190461"]}, {"Citation": "Tripathi M.K., Singh P., Sharma S., Singh T.P., Ethayathulla A.S., Kaur P. Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. J.\u00a0Biomol. Struct. Dyn. 2020:1\u201314. doi: 10.1080/07391102.2020.1790425.", "ArticleIdList": ["10.1080/07391102.2020.1790425", "PMC7441797", "32643552"]}, {"Citation": "Girme A., Saste G., Pawar S., Balasubramaniam A.K., Musande K., Darji B., Satti N.K., Verma M.K., Anand R., Singh R., Vishwakarma R.A., Hingorani L. Investigating 11 Withanosides and Withanolides by UHPLC\u2013PDA and mass fragmentation studies from Ashwagandha (Withania somnifera) ACS Omega. 2020;5:27933\u201327943. doi: 10.1021/acsomega.0c03266.", "ArticleIdList": ["10.1021/acsomega.0c03266", "PMC7643146", "33163776"]}, {"Citation": "Chikhale R.V., Gurav S.S., Patil R.B., Sinha S.K., Prasad S.K., Shakya A., Shrivastava S.K., Gurav N.S., Prasad R.S. Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach. J.\u00a0Biomol. Struct. Dyn. 2020:1\u201312. doi: 10.1080/07391102.2020.1778539.", "ArticleIdList": ["10.1080/07391102.2020.1778539", "PMC7332873", "32568012"]}, {"Citation": "Dutta A., Ghoshal A., Mandal D., Mondal N.B., Banerjee S., Sahu N.P., Mandal C. Racemoside A, an anti-leishmanial, water-soluble, natural steroidal saponin, induces programmed cell death in Leishmania donovani. J.\u00a0Med. Microbiol. 2007;56:1196\u20131204. doi: 10.1099/jmm.0.47114-0.", "ArticleIdList": ["10.1099/jmm.0.47114-0", "17761483"]}, {"Citation": "Chikhale R.V., Sinha S.K., Patil R.B., Prasad S.K., Shakya A., Gurav N., Prasad R., Dhaswadikar S.R., Wanjari M., Gurav S.S. In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19. J.\u00a0Biomol. Struct. Dyn. 2020:1\u201315. doi: 10.1080/07391102.2020.1784289.", "ArticleIdList": ["10.1080/07391102.2020.1784289", "32579064"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "12", "Day": "9"}, {"Year": "2021", "Month": "1", "Day": "25"}, {"Year": "2021", "Month": "2", "Day": "10"}, {"Year": "2021", "Month": "3", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "1", "Hour": "20", "Minute": "17"}, {"Year": "2021", "Month": "2", "Day": "22"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33647752", "PMC7897937", "10.1016/j.jmgm.2021.107874", "S1093-3263(21)00043-7"]}}], "PubmedBookArticle": []}